The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Fri, 25th Sep 2020 16:05

Monday 28 September 
Diageo PLCAGM
Time Out Group PLCAGM
Mulberry Group PLCAGM
Van Elle Holdings PLCAGM
Mereo BioPharma Group PLCAGM
Christie Group PLCAGM
Galileo Resources PLCAGM
Eddie Stobart Logistics PLCGM re financial statements
Challenger Acquisitions LtdAGM
Avon Rubber PLCGM re Team Wendy purchase
Tuesday 29 August 
PV Crystalox Solar PLCGM re tender offer
Raven Property Group LtdGM re tender offer
Novacyt SAAGM
Gama Aviation PLCAGM
Ince Group PLCAGM
IMImobile PLCAGM
Brickability Group PLCAGM
DCD Media PLCAGM
Jaywing PLCAGM
Carclo PLCAGM
Arcontech Group PLCAGM
Amigo Holdings PLCGM re Richmond Group resolutions
Rockfire Resources PLCGM re articles of association amendment
Appreciate Group PLCAGM
Augmentum Fintech PLCAGM
Wednesday 30 September 
Active Energy Group PLCAGM
Anglesey Mining PLCAGM
Catena Group PLCAGM
Chenvari Capital Solutions LtdEGM re base currency change to euro
City of London Group PLCAGM
Clipper Logistics PLCAGM
Creightons PLCAGM
daVictus PLCAGM
Distribution Finance Capital Holdings PLCAGM
HML Holdings PLCAGM
IntegraFin Holdings PLCGM re hybrid general meetings
Marlowe PLCAGM
Mobile Tornado Group PLCAGM
Motif Bio PLCAGM
Powerhouse Energy Group PLCAGM
Purplebricks Group PLCAGM
Renishaw PLCAGM
San Leon Energy PLCAGM
Sosandar PLCAGM
Studio Retail Group PLCAGM
Tekmar Group PLCAGM
TheWorks.co.uk PLCAGM
Yew Grove REIT PLCEGM re gearing level
Thursday 1 October 
Abbey PLCAGM
Anglo African Oil & Gas PLCAGM
Boston International Holdings PLCAGM
Friday 2 October 
Cobra Resources PLCGM re power to allot shares
Just Eat Takeaway.com NVEGM re Grubhub acquisition
NCC Group PLCAGM
Tiziana Life Sciences PLCGM re Accustem Sciences Ltd demerger
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
7 Feb 2019 11:40

Tiziana Life Sciences Non-Exec Director Riccardo Dalla-Favera Resigns

LONDON (Alliance News) - Tiziana Life Sciences PLC on Thursday said Non-Executive Director Riccardo Dalla-Favera has resigned from his role."The company is grateful to Favera for his

Read more
3 Dec 2018 14:27

Tiziana completes patient enrolment in ongoing Milciclib study

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Monday that patient enrolment in its ongoing Phase 2a clinical trial, known as CDKO-125A-010, was now completed.

Read more
3 Dec 2018 11:51

Tiziana Life Completes Patient Enrollment In Liver Cancer Trial

LONDON (Alliance News) - Tiziana Life Sciences PLC on Monday said it completed patient enrollment in a Phase 2a trial of Milciclib in hepatocellular carcinoma.The company explained that the

Read more
28 Nov 2018 12:19

Tiziana Life Sciences Begins First-In-Human Phase 1 Trial Of Foralumab

LONDON (Alliance News) - Tiziana Life Sciences PLC on Wednesday said it began the first in-human trial of Foralumab, a treatment for autoimmune diseases.The biotechnology company said the a

Read more
20 Nov 2018 12:53

Tiziana Life Sciences Prices ADS Offering, Raises GBP3.4 Million

LONDON (Alliance News) - Tiziana Life Sciences PLC said Tuesday that it has priced its underwritten public offering in the US of 442,910 American Depositary Shares representing ordinary shares in

Read more
25 Sep 2018 13:43

Tiziana Life Seeks Listing Of ADS On Nasdaq Capital Market (ALLIPO)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Tuesday that it has commenced underwritten public offering in the US of American Depositary Shares representing ordinary shares in the UK of

Read more
24 Sep 2018 12:37

Tiziana Half-Year Loss Unchanged; Gets US Approval For Foralumab Trial

LONDON (Alliance News) - Tiziana Life Sciences PLC on Monday reported a flat loss in the first half of 2018 as expenses were broadly unchanged, while the biotechnology firm also announced that its

Read more
17 Aug 2018 11:39

DIRECTOR DEALINGS: Tiziana Life Chairman Associate Buys Shares

LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday that Panetta Partners Ltd, a company associated with Chairman Gabriele Cerrone, bought shares in the company worth acquired 469,766 a

Read more
16 Aug 2018 11:47

Tiziana seeks trial for multiple sclerosis 'game changer'

(Sharecast News) - Tiziana Life Sciences on Thursday submitted an application to initiate phase one clinical trials for a new treatment of neurodegenerative diseases to the US food and drug administration.

Read more
27 Jul 2018 11:14

Tiziana Life Sciences Files For IPO Of American Depositary Shares (ALLIPO)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday it filed a registration statement with the US Securities Exchange Commission for a proposed initial public offering of its American

Read more
16 May 2018 13:27

Tiziana Life Science Reports Progress In Milcicib Phase 2a Trial

LONDON (Alliance News) - Biotechnology company Tiziana Life Sciences PLC said Wednesday that the phase 2a trial of Milciclib safety and tolerability in patients with Metastatic Hepatocellular has

Read more
19 Apr 2018 14:44

Tiziana Raises GBP825,000 Through Placing Of 1 Million Shares (ALLISS)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Thursday it has raised GBP825,000 from the issue of 1.0 million new shares at a price of 80 pence per share.The cancer and autoimmune

Read more
4 Apr 2018 12:53

Tiziana Appoints Leopoldo Zambeletti As Non-Executive Director

LONDON (Alliance News) - Tiziana Life Sciences PLC, a biotechnology company developing drugs for cancer and autoimmune diseases, said Wednesday Leopoldo Zambeletti has joined

Read more
16 Nov 2016 09:34

Tiziana Life Sciences makes breakthrough oral treatment for inflammatory diseases

(ShareCast News) - Tiziana Life Sciences, the clinical stage biotechnology company, announced that new data has demonstrated the potential of its novel oral therapy with foralumab for non-alcoholic steatohepatitis (NASH), diabetes and other life threatening inflammatory diseases. Oral efficacy in hu

Read more
18 Jul 2016 12:03

Tiziana Life looks for secrets of long life with new acquisition

(ShareCast News) - Tiziana Life Sciences has purchased key assets from Sardinia-based biobanking and genomics research company Shardna for €258,000, giving it access to the genetic data of nearly 13,000 people from the Ogliastra region, where life expectancy is high. The AIM-listed clinical stage bi

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.